Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 30, 2010
Patient perception of dyskinesia in Parkinson's disease
S W Hung, G M Adeli, T Arenovich, et al.
Annals of the New York Academy of Sciences
|
January 30, 1976
Comparison of carbon dioxide laser excision of burns with other thermal knives
J P Fidler, E Law, B G MacMillan, et al.
Neuron
|
November 1, 1994
Distinct electric potentials in soma and neurite membranes
R S Bedlack, M D Wei, S H Fox, et al.
Parkinsonism & Related Disorders
|
August 27, 2020
The selective 5-HT<sub>1A</sub> receptor agonist, NLX-112, exerts anti-dyskinetic effects in MPTP-treated macaques
R Depoortere, T H Johnston, S H Fox, et al.
Experimental Neurology
|
October 30, 2001
Antiparkinsonian action of a delta opioid agonist in rodent and primate models of Parkinson's disease
C J Hille, S H Fox, Y P Maneuf, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 29, 2008
Alpha1-adrenoceptors mediate dihydroxyphenylalanine-induced activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaques
N P Visanji, S H Fox, T H Johnston, et al.
Neuroimaging Clinics of North America
|
July 23, 1998
Future directions in CT technology
S H Fox, L N Tanenbaum, S Ackelsberg, et al.
Radiology
|
August 1, 1978
Benefit/risk analysis of aggressive mammographic screening
S H Fox, M Moskowitz, E L Saenger, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 2, 2001
Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan
S H Fox, B Henry, M P Hill, et al.
Current Opinion in Anaesthesiology
|
October 3, 2006
Strategies to prevent organ failure
J F FitzGerald, S H Fox, J M Civetta, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 30, 2010
Patient perception of dyskinesia in Parkinson's disease
S W Hung, G M Adeli, T Arenovich, et al.
Annals of the New York Academy of Sciences
|
January 30, 1976
Comparison of carbon dioxide laser excision of burns with other thermal knives
J P Fidler, E Law, B G MacMillan, et al.
Neuron
|
November 1, 1994
Distinct electric potentials in soma and neurite membranes
R S Bedlack, M D Wei, S H Fox, et al.
Parkinsonism & Related Disorders
|
August 27, 2020
The selective 5-HT<sub>1A</sub> receptor agonist, NLX-112, exerts anti-dyskinetic effects in MPTP-treated macaques
R Depoortere, T H Johnston, S H Fox, et al.
Experimental Neurology
|
October 30, 2001
Antiparkinsonian action of a delta opioid agonist in rodent and primate models of Parkinson's disease
C J Hille, S H Fox, Y P Maneuf, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 29, 2008
Alpha1-adrenoceptors mediate dihydroxyphenylalanine-induced activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaques
N P Visanji, S H Fox, T H Johnston, et al.
Neuroimaging Clinics of North America
|
July 23, 1998
Future directions in CT technology
S H Fox, L N Tanenbaum, S Ackelsberg, et al.
Radiology
|
August 1, 1978
Benefit/risk analysis of aggressive mammographic screening
S H Fox, M Moskowitz, E L Saenger, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 2, 2001
Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan
S H Fox, B Henry, M P Hill, et al.
Current Opinion in Anaesthesiology
|
October 3, 2006
Strategies to prevent organ failure
J F FitzGerald, S H Fox, J M Civetta, et al.
Page
of 6